IFCI shares fell 7% after a sharp recent rally, after the stock rallied nearly 30% in a month amid Sebi’s approval of the NSE IPO. IFCI has indirect exposure to NSE through its stake in Stock Holding Corporation of India.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the